The Michigan Hospital Medicine Safety Consortium was created in 2010 to improve care of medical patients at risk for hospital associated blood clots, or venous thromboembolisms (VTE). Hospitalists and 51 Michigan hospitals are working together to improve the quality of care for hospitalized medical patients who are at risk for adverse events, such as VTE. This consortium also is addressing peripherally inserted central catheter (PICC) use and antimicrobial (ABX) use.
For more information, go to mi-hms.org
The Hospital Medicine Safety consortium has used a validated identification process for appropriate candidates for VTE prophylaxis. This process is challenging national standards and has been recognized by the Society of Hospital Medicine as one of the top three developments in hospital medicine.
- There has been a statistically significant improvement in the rates of pharmacologic prophylaxis for high risk patients without complications.
- Participating sites showed a 35 percent improvement in patients receiving a risk assessment for potential VTE.
- There is a 36 percent increase in the amount of high risk patients who had mechanical prophylaxis ordered (based on the Padua risk assessment model to define high risk patients).
- For the PICC Use Initiative, baseline data is still being collected by most member hospitals, but improvement is beginning to be seen in the initiative goals.